NYSE:GSK - GlaxoSmithKline SEC Filings & 10K Form

Sign in or create an account to add this stock to your watchlist.
$41.36 +0.07 (+0.17 %)
(As of 02/21/2019 01:29 AM ET)
Previous Close$41.29
Today's Range$41.15 - $41.6050
52-Week Range$35.78 - $42.36
Volume2.60 million shs
Average Volume3.42 million shs
Market Capitalization$102.60 billion
P/E Ratio13.09
Dividend Yield4.65%
Beta0.79

SEC Filings

GlaxoSmithKline (NYSE:GSK) SEC Filings

DateFilerForm TypeView
02/20/2019
9:41 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/19/2019
9:14 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/19/2019
8:59 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/19/2019
8:29 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/19/2019
5:43 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/15/2019
1:14 PM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/15/2019
12:58 PM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/15/2019
12:51 PM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/14/2019
7:01 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/12/2019
10:35 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/12/2019
10:07 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/11/2019
7:37 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/11/2019
7:36 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/11/2019
7:20 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/11/2019
7:14 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/11/2019
6:44 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/08/2019
7:13 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/08/2019
7:03 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/06/2019
12:39 PM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/06/2019
7:06 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/05/2019
6:51 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/01/2019
9:55 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
01/23/2019
7:37 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
01/22/2019
8:35 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
01/22/2019
8:04 AM
GlaxoSmithKline (Filed by)
TESARO, Inc. (Subject)
Form SC TO-T/A
View Filing
01/22/2019
5:36 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
01/16/2019
7:17 PM
GlaxoSmithKline (Filed by)
TESARO, Inc. (Subject)
Form SC TO-T/A
View Filing
01/15/2019
3:57 PM
GlaxoSmithKline (Reporting)
Principia Biopharma Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/15/2019
12:32 PM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
01/15/2019
11:20 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
01/15/2019
10:29 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
01/15/2019
10:18 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
01/15/2019
10:03 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
01/15/2019
9:22 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
01/15/2019
6:44 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
01/15/2019
6:19 AM
GlaxoSmithKline (Filed by)
TESARO, Inc. (Subject)
Form SC TO-T/A
View Filing
01/11/2019
1:22 PM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
01/11/2019
12:28 PM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
01/07/2019
4:13 PM
GlaxoSmithKline (Filed by)
TESARO, Inc. (Subject)
Form SC TO-T/A
View Filing
01/02/2019
10:35 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
12/20/2018
11:46 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
12/19/2018
5:16 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
12/18/2018
3:58 PM
GlaxoSmithKline (Filed by)
TESARO, Inc. (Subject)
Form SC TO-T/A
View Filing
12/17/2018
4:03 PM
GlaxoSmithKline (Filed by)
TESARO, Inc. (Subject)
Form SC TO-T/A
View Filing
12/14/2018
7:41 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
12/14/2018
7:06 AM
GlaxoSmithKline (Filed by)
TESARO, Inc. (Subject)
Form SC TO-T
View Filing
12/12/2018
11:31 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
12/04/2018
4:25 PM
GlaxoSmithKline (Filed by)
TESARO, Inc. (Subject)
Form SC TO-C
View Filing
12/04/2018
5:58 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
12/03/2018
8:55 PM
GlaxoSmithKline (Filed by)
TESARO, Inc. (Subject)
Form SC TO-C
View Filing
12/03/2018
9:29 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
12/03/2018
9:16 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
12/03/2018
8:07 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
11/29/2018
10:58 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
11/29/2018
7:57 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
11/27/2018
10:12 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
11/23/2018
5:52 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
11/13/2018
6:25 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
11/13/2018
5:32 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
11/08/2018
7:01 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
11/02/2018
12:08 PM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
11/01/2018
9:10 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
10/31/2018
1:09 PM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
10/31/2018
9:38 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
10/30/2018
11:41 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
10/29/2018
6:19 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
10/18/2018
4:03 PM
ChemoCentryx, Inc. (Issuer)
GlaxoSmithKline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
10/18/2018
4:02 PM
ChemoCentryx, Inc. (Subject)
GlaxoSmithKline (Filed by)
Form SC 13D/A
View Filing
10/18/2018
10:49 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
10/18/2018
5:05 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
10/17/2018
12:55 PM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
10/17/2018
12:46 PM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
10/17/2018
7:00 AM
GlaxoSmithKline (Filed by)
Translate Bio, Inc. (Subject)
Form SC 13D/A
View Filing
10/17/2018
6:16 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
10/16/2018
1:10 PM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
10/16/2018
6:02 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
10/16/2018
5:30 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
10/10/2018
10:00 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
10/01/2018
10:25 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
09/27/2018
11:52 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
09/21/2018
7:06 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
09/20/2018
4:18 PM
GlaxoSmithKline (Reporting)
Principia Biopharma Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/19/2018
3:39 PM
GlaxoSmithKline (Filed by)
Spero Therapeutics, Inc. (Subject)
Form SC 13D/A
View Filing
09/18/2018
3:43 PM
ChemoCentryx, Inc. (Subject)
GlaxoSmithKline (Filed by)
Form SC 13D/A
View Filing
09/14/2018
5:32 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
09/13/2018
4:25 PM
GlaxoSmithKline (Reporting)
Principia Biopharma Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
09/12/2018
12:32 PM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
09/10/2018
5:35 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
09/10/2018
5:30 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
09/07/2018
8:56 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
09/07/2018
8:49 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
09/04/2018
5:44 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
08/30/2018
11:51 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
08/30/2018
6:08 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
08/24/2018
5:58 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
08/15/2018
5:20 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
08/10/2018
9:18 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
08/08/2018
7:12 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
08/07/2018
5:20 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
08/02/2018
7:31 AM
GlaxoSmithKline (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
This page was last updated on 2/21/2019 by MarketBeat.com Staff

Featured Article: Is the QQQ ETF safe?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel